Loading...

Home
Stock
ABVX

ABVX News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ABVX News

Three High-Potential Stocks: Abivax, Krystal Biotech, and Marvell

Abivax, Krystal Biotech, and Marvell's Market Potential

7h agoNASDAQ.COM

Abivax Completes $920M Public Offering with Full Underwriter Option Exercise

5d agoseekingalpha

Abivax Increases Offering to 7.36 Million Shares, Raising $874.1 Million

5d agostocktwits

Abivax Fully Exercises Underwriters' Option for Additional ADS Purchase

6d agoNewsfilter

Abivax Raises $800 Million Through ADS Offering

6d agostocktwits

ABIVAX Prices Public Offering of 6.4 Million ADSs

6d agoNASDAQ.COM

Abivax Prices Oversubscribed $800M Public Offering

6d agoNewsfilter

ABVX Events

Increased Deal Size to $800M in Common Stock

The deal size was increased to $800M in common stock from $600M in common stock. Leerink, Morgan Stanley, Piper Sandler and Guggenheim acted as joint book running managers for the offering.

Leerink, Morgan Stanley, and Others Jointly Manage Offering

Leerink, Morgan Stanley, Piper Sandler and Guggenheim acted as joint book running managers for the offering.

Leerink, Morgan Stanley, and Others Jointly Manage New Stock Offering

Leerink, Morgan Stanley, Piper Sandler and Guggenheim are acting as joint book running managers for the offering.

ABVX Monitor News

Abivax Secures $920 Million from ADS Offering to Boost R&D

Abivax Shares Surge on Positive Phase 3 Data for Ulcerative Colitis

Abivax SA stock rises amid sector rotation

Abivax SA hits 5-day low amid sector rotation

Abivax Faces Investigation After Troubling Phase 3 Trial Results

Abivax Faces Investigation After Negative Phase 3 Trial Results

Abivax Faces Investigation Amid Negative Trial Results

Jefferies Downgrades Abivax Amid Cancer Concerns

ABVX Earnings Analysis

No Data

No Data

People Also Watch